Launch Accelerator
Accelerate peak revenue and maximize brand launch success
42%
of drug launches fail to meet their 2-year forecasts
45%
of biopharma companies delay their drug launches
58
of biopharma companies lower their launch expectations by 25%
Accelerate payer engagement and activation
Break through MLR bottlenecks at 2-3x the speed
Rapidly reach and convert more prescribers
Cut weeks out of the RWE feedback loop from patient to prescriber
Accelerate first prescription through digital KOL engagement
Make the most of human creativity and artificial intelligence
We write to express our deep admiration for Pfizer's unwavering commitment to its vision of
"Breakthroughs that change patients' lives." Your dedication to making a meaningful impact
on patients and society mirrors the enduring values and purpose that drive Pfizer to excellence.
Pfizer's vision, as articulated, embodies a profound understanding of the vital role that
purpose-driven companies play in today's dynamic healthcare landscape. Your emphasis on
breakthroughs to change the lives of patients resonates powerfully and serves as an inspiration
to all of us in the life sciences industry.
Our exclusive report for Pfizer titled ‘Maximize launch success in 5 easy steps’ has been
meticulously crafted to elucidate the critical importance of brand launch success, the common
challenges brands encounter, and the precise strategies to maximize the success of these
life-changing innovations. As a digital-first, life sciences commercialization company, we extend
our heartfelt wishes for Pfizer's forthcoming launches to be marked by resounding success.
Hope this report contributes to Pfizer's ambition to "Change a billion lives a year."
Gaurav Kapoor
EVP of Indegene Inc.
